Coordinated Disclosure

​Researchers engaging in coordinated vulnerability disclosure with BIO-ISAC are expected to comply with the following ethics practices and principles: 
 

• Do not cause any harm to the stakeholder(s), its customers, suppliers, partners or any other individuals or companies; 

• Do not act so as to compromise the safety of any products, their operation, and/or related services; 

• Do not infringe any applicable intellectual property rights or trade secrets, laws, or regulations; 

• Do not lock, disclose, destroy or compromise the integrity of the company’s customers and partners’ data 

• Do not turn a financial transaction into a precondition to the disclosure of potential vulnerability; 

• Do not breach any applicable laws and regulations, particularly those related to cybersecurity research and data privacy. 

• Do not exploit or compromise the vulnerability(s) or vulnerable systems.

 

Ethical disclosure guidelines are designed to ease the disclosure of potential vulnerabilities in a collaborative way and in accordance with the law. This process shall not be construed as a permission to infringe any law or to reverse engineer any code or other technology. BIO-ISAC requires that stakeholder(s) be given time to assess and fix vulnerabilities before public disclosure and routinely engages its community to collaborate with and support vendors during this process.​